MyMD Pharmaceuticals, Inc. (MYMD)
Total Valuation
MYMD has a market cap or net worth of $5.00 million. The enterprise value is -$3.38 million.
Market Cap | 5.00M |
Enterprise Value | -3.38M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
Earnings Date | May 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MYMD has 2.09 million shares outstanding. The number of shares has increased by 15.12% in one year.
Shares Outstanding | 2.09M |
Shares Change (YoY) | +15.12% |
Shares Change (QoQ) | +11.39% |
Owned by Insiders (%) | 4.36% |
Owned by Institutions (%) | 10.42% |
Float | 1.52M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.32 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.01.
Current Ratio | 1.71 |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.40% and return on invested capital (ROIC) is -97.86%.
Return on Equity (ROE) | -52.40% |
Return on Assets (ROA) | -30.40% |
Return on Capital (ROIC) | -97.86% |
Revenue Per Employee | n/a |
Profits Per Employee | -$707,209 |
Employee Count | 10 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.54% in the last 52 weeks. The beta is 3.26, so MYMD's price volatility has been higher than the market average.
Beta (1Y) | 3.26 |
52-Week Price Change | -94.54% |
50-Day Moving Average | 3.70 |
200-Day Moving Average | 17.26 |
Relative Strength Index (RSI) | 30.67 |
Average Volume (30 Days) | 51,525 |
Short Selling Information
The latest short interest is 93,380, so 4.46% of the outstanding shares have been sold short.
Short Interest | 93,380 |
Short Previous Month | 92,705 |
Short % of Shares Out | 4.46% |
Short % of Float | 6.16% |
Short Ratio (days to cover) | 2.20 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -15.26M |
Pretax Income | -5.38M |
Net Income | -7.07M |
EBITDA | -5.38M |
EBIT | -5.38M |
Earnings Per Share (EPS) | -$5.40 |
Balance Sheet
The company has $8.47 million in cash and $93,145 in debt, giving a net cash position of $8.38 million or $4.01 per share.
Cash & Cash Equivalents | 8.47M |
Total Debt | 93,145 |
Net Cash | 8.38M |
Net Cash Per Share | $4.01 |
Equity / Book Value | 15.50M |
Book Value Per Share | 7.41 |
Working Capital | 4.04M |
Cash Flow
Operating Cash Flow | -13.30M |
Capital Expenditures | n/a |
Free Cash Flow | -13.30M |
FCF Per Share | -$8.87 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MYMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -15.12% |
Shareholder Yield | -15.12% |
Earnings Yield | -141.47% |
FCF Yield | -265.98% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 15, 2024. It was a reverse split with a ratio of 1:30.
Last Split Date | Feb 15, 2024 |
Split Type | Reverse |
Split Ratio | 1:30 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |